Narrow Results

Study Leave Benefits Queensland Doctors.

Breast Cancer and Family History Link to be Investigated.

Study on Burden of Obesity and Diabetes.

China Rapidly Developing Biotechnology and Bioindustry.

China to Build World's Largest Chinese Bone Marrow Bank.

Influenza Major Cause of Hospitalization of Children.

India Needs Better Biotech Policy.

Online Database for Cancer Therapies.

US Corn Cargo Sold to Japan Contains Banned Organism.

Korea Invests in Biochemical Technology.

Korea's Big Biotechnology Plans for 2003.

Scientists Confirm Toxicity of Fungus Found in Homes.

School Based Health Care to be Improved.

Taiwan has East Asia's Highest Rate of Gout.

Biotech start-ups in Singapore.

In the modern era, nanotechnology is one of the rapidly growing fields in many biomedical applications especially in delivering therapeutics for the curation of tumor cells. Cancer is a lethal disease that grows silently in the human body, caused by mutations in the genetic material of cells. The presence of a high number of physiologically active chemicals on the cancer cell surface does not particularly lead to tumor cell targeting. The lack of effective targeting of tumor cells by conventionally administered chemotherapeutic drugs demands the use of nanomedicine. Conventional medicines have immense cytotoxic effects, i.e., they do not kill tumor cells only but also destroy normal body cells. Nanoparticles (NPs) have an advantage over conventional therapeutic methods due to their small size, large surface area, and especially for targeting tumor cells without harming normal body cells. Based on durability and molecular weight, NPs are classified as organic and inorganic nanoparticles. Common organic and inorganic nanoparticles are highly effective against cancer curation and have high efficacy values along with their mechanism of action.